Tag: Funding

Cardiva Medical Brings Total Financing Round to $41 Million; Announces Sponsorship of AMBULATE Trial, First Vascular Closure Trial Targeted at High Growth Electrophysiology Procedures

New Vascular Closure Device for Multi-Access Mid-Bore Vein Procedures, Specifically Cardiac Ablation, Aims to Reduce Time to Ambulation and Improve the Patient Experience SANTA CLARA, Calif.–(BUSINESS WIRE)– Cardiva Medical ®, an innovator in the field of vascular closure, today announced that the company has closed on $11 million in additional financing – […]

Perflow Medical Closes $12 Million in Financing to Treat Complex Neurovascular Disorders

TEL AVIV, Israel, Feb. 15, 2018 /PRNewswire/ — Perflow Medical, an Israeli-based medical device company that develops innovative tools for neurovascular interventions, today announced that the company has closed $12 million in financing. The syndicate included existing investors, two new international investors, and an unnamed strategic investor. Following a recent launch in Europe, Perflow stated that […]

CHF Solutions, Inc. Announces Closing of $18.0 Million Underwritten Public Offering

EDEN PRAIRIE, Minn., Nov. 27, 2017 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ:CHFS) announced today the closing of an underwritten public offering of Series F convertible preferred stock, together with warrants, for gross proceeds of $18.0 million, prior to deducting underwriting discounts and commissions and offering expenses payable by CHF […]

EBR Systems, Inc. Raises $50 Million to Complete Global Heart Failure Trial

SUNNYVALE, Calif.–(BUSINESS WIRE)–EBR Systems, Inc., developer of the world’s first and only wireless cardiac pacing system for heart failure, has raised $50 million to conduct the global SOLVE-CRT study. The financing was led by Australian private equity firms M.H. Carnegie & Co. and Brandon Capital Partners and included participation by […]

Xeltis Closes $52M for Replacement Heart Valve Programs

EINDHOVEN, The Netherlands and ZURICH, November 15, 2017 /PRNewswire/ — Xeltis, a clinical-stage medical device company pioneering a restorative approach in heart valve therapy, today announced the completion of an oversubscribed EUR45 million ($52 million) Series C financing. The funding round was led by a global strategic investor with participation […]

Allied Minds’ Portfolio Company Signature Medical Raises $2.5 Million in Series A Financing

BOSTON–(BUSINESS WIRE)–Signature Medical, Inc. (Signature Medical), an Allied Minds (LSE: ALM) portfolio company, today announced that it has completed a $2.5 million Series A funding round, including participation from Riot Ventures, an early stage investment group focused on emerging technologies; Bose Corporation, a global leader in audio innovation; and Allied […]

SoCal’s Endologix Gets $170 Million Injection to Advance Aortic Disorder Treatment

Endologix Enters into $170 Million Credit Facility with Deerfield Management IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it has entered into an agreement with Deerfield Management (“Deerfield”), a leading healthcare investment organization, to provide Endologix with up to $170 […]